HomepageOCEAW • NASDAQ
add
Ocean Biomedical
Vorige slotkoers
$ 0,040
Dag-range
$ 0,036 - $ 0,039
Jaar-range
$ 0,019 - $ 0,68
Beurswaarde
35,00 mln. USD
Gem. volume
41,92K
Marktnieuws
MarketWatch
17 uur geleden
These 6 charts suggest caution as the S&P 500 hits 47th record high of 2024
0,40%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2023info | Wijziging j-o-j |
|---|---|---|
Opbrengst | — | — |
Bedrijfskosten | 2,66 mln. | -16,33% |
Netto inkomsten | -14,09 mln. | -284,05% |
Netto winstmarge | — | — |
Winst per aandeel | -0,52 | — |
EBITDA | — | — |
Effectief belastingtarief | — | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2023info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 31,00K | -73,28% |
Totale activa | 1,03 mln. | -9,08% |
Totale passiva | 76,26 mln. | 595,12% |
Totaal aandelenvermogen | -75,22 mln. | — |
Uitstaande aandelen | 34,65 mln. | — |
Koers-boekwaardeverhouding | -0,02 | — |
Rendement op activa | -415,88% | — |
Rendement op kapitaal | 12,88% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2023info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -14,09 mln. | -284,05% |
Operationele kasstroom | -1,13 mln. | -155,66% |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | 0,00 | -100,00% |
Nettomutatie in liquide middelen | -1,13 mln. | -303,57% |
Vrije kasstroom | -833,50K | — |
Over
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Opgericht
2019
Hoofdvestiging
Website
Werknemers
9
